About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, June 19th, 2017

The QualityStocks
Daily Stock List


Black Ridge Oil & Gas, Inc. (ANFC)

TopPennyStockMovers, Wall Street Resources, and Wall Street Reporting reported earlier on Black Ridge Oil & Gas, Inc. (ANFC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Black Ridge Oil & Gas, Inc. is a growth-oriented oil and gas exploration and production company. It is concentrating on non-operated Bakken and Three Forks properties. At present, Black Ridge controls more than 10,000 net Bakken and/or Three Forks acres. The Company’s focus is exclusive to the Williston Basin Bakken and the Three Forks trend in North Dakota and Montana. The Company is one of the premier non-operating participants in the Bakken and Three Forks play.  Black Ridge Oil & Gas has its headquarters in Minnetonka, Minnesota. The Company lists on the OTC Markets Group’s OTCQB.

Black Ridge Oil & Gas closed its debt restructuring agreement on June 21, 2016. It remains a public company and its strategy shifted from asset owner to asset
Manager. The Company receives short term income from management fees from the different joint ventures (JVs) - Black Ridge Holding Company, LLC initially; Merced Black Ridge, LLC (established July 2015), and others as it makes acquisitions.

In essence, Black Ridge Oil & Gas centers on its asset management business and partnering with investment sponsors to acquire oil and gas assets. Furthermore, the Company concentrates on energy loans and providing capital for oil and gas drilling/completion projects.

Black Ridge Oil & Gas takes a minority rather than majority interest in its wells. This strategy produces a highly-diversified portfolio of Bakken and Three Forks wells throughout the Williston Basin for the Company. Currently, Black Rudge manages Working Interest (WI) in more than 350 gross Bakken and/or Three Forks wells producing roughly 1,500 net BOEPD (Barrels of Oil Equivalent Per Day).

Black Ridge Oil & Gas, along with its capital providers, is working to acquire oil and gas assets across the major U.S. onshore basins. Black Ridge has participated in drilling more than 300 Bakken or Three Forks wells in North Dakota and Montana since 2010. The Company - being a non-operator - participates in Bakken and Three Forks wells on a proportionate basis according to its leasehold interest in each drilling unit drilled by its operating partners.

Regarding its Merced Black Ridge Partnership, Merced provides equity capital and this capital is used to acquire/develop non-operated assets in all U.S. onshore basins. Black Ridge sources deals and manages day to day business.

Black Ridge Oil & Gas, Inc. (ANFC), closed Monday's trading session at $0.0175, down 7.89%, on 13,000 volume with 2 trades. The average volume for the last 60 days is 22,440 and the stock's 52-week low/high is $0.0121/$0.1062.

Quantum Materials Corp. (QTMM)

SmallCapVoice, Stock News Now, TopPennyStockMovers, PennyStocks Forever, BUYINS.NET, Bullseyestox, TheMicrocapNews, PricelessPenny, PennyStockRumors.net, AddictivePennyStocks, PennyStocks24, Penny Stock Pick Report, Liquid Tycoon, PennyStockMoneyTrain, Pumps and Dumps, Super Hot Penny Stocks, Super Nova Stock Picks, StockMister, WePickPennyStocks, and Winning Penny Stock Picks reported on Quantum Materials Corp. (QTMM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Quantum Materials Corp. develops and manufactures quantum dots and nanomaterials for use in display, solar energy, and lighting applications via its proprietary high-volume continuous-flow production process. Tetrapod Quantum Dot semiconductors allow for a new level of engineered performance for consumer and industrial products. Quantum Materials has its wholly-owned subsidiary, Solterra Renewable Technologies, Inc. Solterra develops sustainable quantum dot solar technology.  Quantum Materials is based in San Marcos, Texas.

The Company's volume manufacturing methods enable consistent quality and scalable cost reductions to provide the basis for technologically superior, energy efficient, and environmentally-sound LCD UHD displays, the next generation of solid-state lighting and solar photovoltaic power applications. Quantum Materials entered into an agreement in 2015 with Uniglobe Kisko, Inc. for distribution of advanced QMC quantum dot and related nanomaterials.

Quantum dots fall into the category of nanocrystals. This also includes quantum rods and nanowires. Quantum Dots measure close to one billionth of an inch. They are a non-traditional kind of semiconductor. They can be utilized as an enabling material across numerous industries. They have first-class versatility and are flexible in form.  

Solterra Renewable Technologies develops sustainable solar technology through replacing silicon wafer-based solar cells with high-production, low-cost, efficient and flexible thin-film quantum dot solar cells. Solterra’s aim is to market a thin-film photovoltaic cell incorporating its proprietary quantum dot semiconductors.    

Solterra will use Quantum Materials’ exclusive license from University of Arizona Regents for Dr. Ghassan Jabbour’s patented printing technology in the production of its solar cells. Solterra’s goal is to become the first solar cell manufacturer that can provide a solar electricity solution, which competes on a non-subsidized basis with the price of retail electricity in the abovementioned key markets.

Quantum Materials has secured 3D printing and additive manufacturing anti-counterfeiting quantum dot detection technology. The technology embeds quantum dots within objects being 3D printed to produce an innovative, physically uncloneable signature known only to the object's manufacturer.

Quantum Materials launched its new QDX™ class of high-stability Cadmium-free quantum dots. QDX™ Quantum Dots do not degrade under the high heats used in application to film, silicon, and polymer. They allow for creative LCD display and LED lighting engineering and lowering protective barrier film costs. Quantum Materials has also partnered with a Texas-based E&P technology business. Quantum is now developing specialized nanomaterials for use in oil and gas well production optimization.
In April, Quantum Materials and Freschfield PLC announced the execution of a funded collaboration agreement. Quantum will work with Freschfield to integrate Quantum Materials’ advanced Nanomaterials including quantum dot-based solar photovoltaics into Freschfield's SmartSkinz. Freschfield has synthesized solar and hydrogen fuel cell technologies into an outer layer building skin – SmartSkinz – that creates a perpetual carbon-free energy source, under any weather condition, time of day, and location.

Last month, Quantum Materials announced that the United States Patent and Trademark Office (USPTO) granted the Company Patent # 9577149 for the continuous synthesis of high quantum yield InP/ZnS nanocrystals. United States Patent # 9577149 encompasses the continuous-flow synthesis process for the preparation of high quality indium phosphide/zinc sulfide core/shell semiconducting nanocrystals – more specifically quantum dots (QD) -  conducted in a micro-reaction system consisting of at least one mixing chamber connected to one reaction chamber.

Quantum Materials Corp. (QTMM), closed Monday's trading session at $0.12, even for the day, on 102,213 volume with 29 trades. The average volume for the last 60 days is 447,078 and the stock's 52-week low/high is $0.0645/$0.249.

Vapir Enterprises, Inc. (VAPI)

RedChip reported previously on Vapir Enterprises, Inc. (VAPI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Vapir Enterprises, Inc. is a developer and manufacturer of cutting-edge, state-of-the-art, and user-friendly vaporization devices. The Company has diverse issued and pending patents. Its vaporizers extract active ingredients from source material through an innovative and proprietary process. This delivers high quality natural vapor for a first-rate user experience. Vapir invents, develops, and produces digital vaporizers in desktop and portable varieties. Vapir Enterprises is headquartered in California.

Vapir specializes in the pioneering technology of digital vaporization. The process of vaporization extracts all of the therapeutically beneficial compounds from choice herbs and flowers into a vapor cloud.

The Company’s vaporizers use hot air instead of direct contact with a heating element. This produces smooth, well-balanced exposure, which Vapir says results in a very flavorful and potent vapor cloud.

Its vaporizer models include PRIMA (the digital vaporizer supports herbs and extracts), VAPIRISE 2.0 (designed for loose-leaf herbs and essential oils); NO2.V2 (designed for loose-leaf herbs and direct inhalation), and Oxygen Mini (designed for loose-leaf herbs direct inhalation).

In January of this year, Vapir Enterprises announced the launch of the Vapir Pen. This product is a high quality portable pen vaporizer with a Micro USB charging port. This feature permits the device to undergo charging with any regular USB charger anywhere. The Vapir Pen became available on January 15, 2017 on Vapir's website.

In March, Vapir Enterprises announced that its new Vapir Pen is available through VaporNation.com. The Vapir Pen is part of its premium line of vaporizers. The Vapir Pen portable vaporizer features a sleek design with an ergonomic mouthpiece, two kinds of atomizers, and also three temperature settings.

Vapir Enterprises’ line of premium vaporizers, including the Vapir Pen, are available around the world through the e-commerce retail channels of Namaste Technologies, Inc. Namaste Technologies is an international distributor of vaporizers and related products.

Namaste operates more than 24 e-commerce retail stores in 20 countries. VaporSeller.com, GreenVapes.com, and other Namaste online stores offer a broad range of quality vaporizers. These include the Prima, VapiRise, NO2, and Vapir Pen. In addition, Namaste sites will carry accessories for Vapir vaporizers.

In 2016, Spherix Incorporated (SPEX) announced that its Intellectual Property (IP) consulting subsidiary signed a Patent Monetization and Consulting Agreement with Vapir Enterprises.  With this Agreement, Spherix will conduct a detailed review of Vapir's patent portfolio and develop a monetization program for Vapir. Spherix is an IP development company dedicated to the fostering of technology and monetization of IP.

Vapir Enterprises, Inc. (VAPI), closed Monday's trading session at $0.034, up 13.33%, on 6,000 volume with 5 trades. The average volume for the last 60 days is 54,676 and the stock's 52-week low/high is $0.01/$0.25.

Orgenesis, Inc. (ORGS)

Stock News Now, Streetwise Reports, Greenbackers, SmallCapNetwork, OTCPicks, IRGnews Alert, and PastWellness reported previously on Orgenesis, Inc. (ORGS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Orgenesis, Inc. is a fully-integrated cell therapy and contract development and manufacturing company. It has a novel therapeutic technology for the treatment of diabetes. Furthermore, the Company has a fully-owned subsidiary contract manufacturing and development company -  MaSTherCell S.A. (Belgian subsidiary). This subsidiary’s devotion is to cell therapy for advanced medicinal products. MaSTherCell (a full-service contract development and manufacturing organization (CDMO)) specializes in the delivery of optimized process industrialization capacities to cell therapy organizations, Orgenesis has its corporate headquarters in Germantown, Maryland.

The Company has expertise and unique experience in cell therapy development and manufacturing. In addition, through its Israeli subsidiary, Orgenesis Ltd., Orgenesis is a pioneer in the development of technology designed to successfully reprogram human liver cells into glucose-responsive, fully functional, Insulin Producing Cells (IPCs).

Orgenesis has a novel therapeutic approach in the treatment of diabetes through correcting malfunctioning organs with new functional tissues created from the patient’s own existing organs. The Company uses a molecular and cellular approach directed at transforming liver cells into functional insulin-producing cells as a treatment for diabetes. The new therapeutic approach is called Autologous Insulin Producing (AIP) cell transplantation.

Orgenesis has demonstrated promising results in in-vitro and in-vivo studies using human liver tissues. It designed an efficient and clear work-plan to commence clinical testing soon, allowing it to launch Phase I clinical trials following Food and Drug Administration (FDA) guidelines followed by the launch of Phase II clinical trials within a year.

In March of this year, Orgenesis reported that Revenue for the fiscal year ending November 30, 2016 grew 115 percent to $6.4 million from $3.0 million in fiscal 2015. This is because of the growth of MaSTherCell, the Company’s cell therapy manufacturing subsidiary.

Via its Israeli subsidiary, Orgenesis continues to advance its innovative cell-based therapy, the Autologous Insulin Producing (AIP) cells, into clinical development. AIP cells use the technology of 'cellular transdifferentiation' to transform an autologous adult liver cell into a fully functional and physiologically glucose-responsive insulin-producing cell.

This month, CRISPR Therapeutics AG (CRSP) and MaSTherCell SA announced the signing of an agreement to develop and manufacture allogeneic CAR-T therapies. CRSP is a leader in gene-editing based therapeutics. MaSTherCell will be responsible for the development and cGMP manufacturing of CTX101 for use in clinical studies. CTX101 is an allogeneic CAR T-cell therapy now in development by CRISPR Therapeutics for the treatment of CD19 positive malignancies.

Orgenesis, Inc. (ORGS), closed Monday's trading session at $0.53, up 2.12%, on 550 volume with 3 trades. The average volume for the last 60 days is 10,713 and the stock's 52-week low/high is $0.2826/$0.98.

Advanced BioMedical Technologies, Inc. (ABMT)

Zacks reported on Advanced BioMedical Technologies, Inc. (ABMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Advanced BioMedical Technologies, Inc. manufactures and distributes advanced impedance controlled micro-current instruments. The Company has treated more than 15,000 patients during the past 28 years. Advanced BioMedical Technologies’ shares trade on the OTC Markets Group’s OTCQB. The Company has its corporate office in Eagan, Minnesota.

Acuscope products include the Electro-Acuscope 85P (Portable); the Electro-Acuscope 80L; and the Neuroscope 230B. Myopulse products include the Electro-Myopulse 75L (Base Model) and the Electro-Myopulse 75F (used in Fermi Lab Study).

The Electro-Acuscope and Electro-Myopulse instruments feature the most sophisticated computerized, feedback-controlled, energy delivery, micro-current technology available today. The Company has a complete staff of qualified professionals fully trained on this leading-edge technology.

Advanced BioMedical Technologies also has its La Fleur products. These include the Electro-Myopulse 75LN Premium Instrument (Myopulse, Facial and Esthetics), which was developed exclusively by the Company. In addition, Advanced BioMedical Technologies carries a line of Accessories.

The Electro-Acuscope monitors nerve conduction between two electrodes. This is how the current amplitude and voltage output is adjusted and controlled. The Acuscope uses a complex waveform. This waveform imitates a nerve impulse.

The Electro-Myopulse measures the Bio-Impedance of the muscle tissue between the two electrodes. Likewise, this is how the current amplitude and voltage output is adjusted and controlled. The Myopulse uses a sine wave. This sine wave imitates the wave produced when a muscle first contracts.

The design of the Electro-Acuscope 85P (Portable) instrument is for the traveling clinician or patient (with prescription). This instrument is built into a haliburtor case for safe and easy portability.

The Company’s Neuroscope 230B (Home Care Unit) is for personal treatment of sleep, anxiety, as well as pain issues. The product is a personal treatment device for the person on the go. It is also as an adjunct to Acuscope and Myopulse (impedance controlled microcurrent) therapy where extended rehabilitation therapy requires additional treatments at home.

Advanced BioMedical Technologies is the oldest distributor of the Electro-Acuscope and Electro-Myopulse. It has a 6,000-square foot office complex, with 3,000 square feet dedicated as a patient care treatment center. The Company is a leader in education, research, training, and instrument sales and works with doctors and clinicians across the U.S. This includes those in Minnesota, the majority of which have an affiliation with the University of Minnesota.

Advanced BioMedical Technologies, Inc. (ABMT), closed Monday's trading session at $0.20, even for the day, on 20,342,890 volume with 80 trades. The average volume for the last 60 days is 9,458,261 and the stock's 52-week low/high is $0.0016/$0.027.


The QualityStocks
Company Corner


BlastGard International Inc. (BLGA)

The QualityStocks Daily Newsletter would like to spotlight BlastGard International Inc. (BLGA). Today, BlastGard International Inc. closed trading at $0.02295, up 13.61%, on 10,500 volume with 2 trades. The stock’s average daily volume over the past 60 days is 114,824 and its 52-week low/high is $0.004/$0.03.

BlastGard International Inc. (BLGA) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

Blastguard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

BlastGard International Inc. Blog

BlastGard International Inc. News:

BlastGard International Inc. (BLGA) is “One to Watch”

BlastGard International Addresses Company's Trading Activity

Big Trading Volumes for BlastGard International Initiates Due Diligence Report

Bollente Companies, Inc. (BOLC)

The QualityStocks Daily Newsletter would like to spotlight Bollente Companies, Inc. (BOLC). Today, Bollente Companies, Inc. closed trading at $0.9999, up 11.10%, on 7,400 volume with 3 trades. The stock’s average daily volume over the past 60 days is 3,483 and its 52-week low/high is $0.20/$1.21.

Bollente Companies, Inc. (BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Their current focus is on high-efficiency electric tankless water heaters, manufactured and sold under "trutankless", a division of Bollente, including a line of economy tankless water heaters sold under the Vero name. Units are available for both residential and commercial application.

The primary Bollente advantage is their use of advanced technology, superior to previous tankless systems, together with a growing U.S. and global market. Traditional water heaters are one of the costliest appliances to operate. The two primary energy sources used in U.S. homes are electric and natural gas, with less than half of U.S. homes having natural gas available. In addition, there are no significant electric whole home tankless manufacturers.

The U.S. Department of Energy now requires tanks of 55 gallons or more to have efficiency levels requiring expensive heat pumps to achieve. Bollente's trutankless electric tankless water heater employs specialized sensors for constant water temperature, solid state electronics, and proprietary software, resulting in one of the most efficient heat exchangers ever produced. The technology includes smart grid and home automation capabilities, remote control and monitoring, and even smartphone alerts. It also allows adjustable custom power management settings, so that users can further enhance energy usage and performance. It is now estimated that tankless heaters used in every home would save over $8 billion annually in the U.S. alone.

By maintaining 99 percent efficiency, Bollente's trutankless heaters use less energy than tank heaters, while providing the convenience of always-hot water. The system only uses power when there is demand, producing water to exact temperature, within one degree, even with sudden changes to input. Wireless apps allow for remote settings, notifications, and monitoring, and models are compatible with existing home automation and energy management systems. The technology also reduces size, for easy location, and the system's self-flushing design provides up to 20+ years of maintenance free operation, significantly reducing upkeep and replacement costs. This becomes an additional environmental benefit since roughly 8 million used water heaters are dumped in landfills every year.

Bollente has also announced the formation of Bollente International, Inc., a wholly-owned subsidiary, for the international production and sale of trutankless systems. Taking advantage of growing interest in their technology, Bollente International is working with an international manufacturing firm for the production and distribution of trutankless systems throughout Europe, Asia, Australia and New Zealand, with the first step being the testing and certification necessary to meet the various international standards.

Bollente has made electric tankless water heating compelling to a major consumer market, both in and outside the U.S., offering economic as well as operational efficiency and convenience, attractive to builders as well as to end consumers. Disclaimer

Bollente Companies, Inc. Blog

Bollente Companies, Inc. News:

Bollente Companies Increases Presence in Trending Segment of Commercial Construction with Its Smart trutankless Product Line

Award-Winning Luxury Builder Cullum Homes Makes trutankless® the Exclusive Water Heating Solution in its Communities

Bollente Companies, Inc. (BOLC) is “One to Watch”

CD International Enterprises, Inc. (CDII)

The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.00198, up 10.00%, on 3,452,233 volume with 23 trades. The stock’s average daily volume over the past 60 days is 3,020,799 and its 52-week low/high is $0.0001/$5.00.

CD International Enterprises, Inc. (CDII) is a U.S.-based company operating in two primary business segments: mineral trading and consulting services. Headquartered in Deerfield Beach, Florida, with operations centering on the rapid growth of the Chinese economy, CDII allows prospective investors to participate in the considerable opportunities presented by emerging markets in both the People's Republic of China and the Americas.

CDII Minerals, Inc., a wholly-owned subsidiary of CD International, serves as its commodities trading division. Through CDII Minerals, CDII sources, aggregates and distributes iron ore, manganese ore and scrap metals for clients operating throughout China. The company maintains a strategic position between its North and South American suppliers and its Chinese clients, allowing it to both address a niche market opportunity and facilitate more efficient transactions for its customers.

In addition to its mineral trading services, CDII has found success in offering a comprehensive suite of consulting services related to the unique characteristics of business operations in China. In December 2016, the company announced its entry into a two-year corporate agreement with a China-based subsidiary of Everbright International Construction Engineering Corporation, through which CDII will provide information related to foreign and domestic constructions, project tending offers, government communications and local networks. In January 2017, CDII announced its entry into a similar agreement with Zhangjiajie Shengshi Agricultural Development Company, through which it will provide consulting services related to a number of business developments, including the development of a distribution business centered on cannabidiol extract derived from industrial hemp.

Per the company's website, CDII's greatest strength lies in the quality of its personnel, which includes a culturally diverse group of professionals operating within the United States, as well as in China and emerging markets throughout the Americas. Dr. James Wang has served as CEO and chairman of the CDII board since August 2006. He has also served as CEO and chairman of China Direct Investments since January 2005. Wang brings a wealth of experience in corporate finance in the U.S. capital markets to the CDII management team, and his work in the identification and acquisition of China-based growth companies has played an instrumental role in the execution of CD International's strategic vision for over a decade.

Wang is joined on the CDII management team by Controller Shirley Xu and Vice President of Business Development Katie Zhao. Xu has served as the company's controller since January 2013, assuming a range of responsibilities including internal control, general ledger accounting oversight, and financial reporting for CDII and its subsidiaries. She is also responsible for SEC financial reporting for the company's consulting segment clients.

Katie Zhao has served in her current role with CD International since January 2012. Prior to becoming VP of business development, she served as the company's project manager from 2007 to 2009 and as senior account executive from 2010 to 2011. From these positions, Zhao played a key role in the establishment of CDII's U.S. distribution channels for its Chinese clients, as well as the implementation of a network connecting the company's U.S. and China-based offices. Disclaimer

CD International Enterprises, Inc. Blog

CD International Enterprises, Inc. News:

CD International Enterprises Signs Full Corporate Offer to Purchase 1.2 Million Tons of Metallurgical Grade Bauxite

CD International Enterprises Enters Wholesale Distribution Agreement With Leading Global Supplier of Cannabidiol/Hemp-Derived Products

CD International Enterprises (OTC: CDII) Enters a Full Corporate Offer To Purchase Copper Cathodes Valued at Approximately $330 Million

India Globalization Capital, Inc. (IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital, Inc. (NYSE: IGC). Today, India Globalization Capital, Inc. closed trading at $0.4165, up 1.59%, on 220,167 volume with 466 trades. The stock’s average daily volume over the past 60 days is 327,796, and its 52-week low/high is $0.19/$0.80.

India Globalization Capital, Inc. (IGC) is a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.

The national cost of health care due to pain ranges from $560 billion to $635 billion. In addition, the health care cost attributed to the abuse of prescription opioids, closely related to pain, is approximately $25 billion. IGC's patent filing (IGC-501) is a cannabis-based formulation addressing neuropathic and arthritic pain in joints and muscles using a variety of delivery techniques. The Company anticipates commencing clinical trials, and hopes that through its focus on combination therapy it can formulate and commercialize cannabinoid compounds as an alternative to long-term addictive opioid treatments.

The Company has also filed combination therapy formulations for the treatment of epilepsy and cachexia. About 50 million people worldwide are affected by epilepsy and about 1.3 million in the U.S. experience cachexia associated with cancer, MS, Parkinson's, HIV/AIDS and other progressive illnesses. Cancer-induced anorexia/cachexia is responsible for 20% of all cancer deaths. IGC-502 indicated for seizures and IGC-504 indicated for cachexia are unique combination therapies that, if proven out by clinical trials, are expected to treat medical refractory epilepsy and eating disorders respectively, with lower side effects than conventional mono therapies.

IGC's strategy is exciting and unique in that it is aiming to become a leader in the phytocannabinoid-based combination therapy specialty pharmaceutical sector. This first mover advantage can potentially be formidable as it begins clinical trials and further builds its patent portfolio. "The development of combination therapies utilizing cannabis represents a large, unique opportunity in this emerging specialty-pharmaceutical sector. Securing FDA approval for combination therapy is believed to be significantly faster and less expensive than new drug applications. As a result, we believe that we can bring our cannabis-based pharmaceutical products to market in both an expeditious and cost-effective manner," stated Ram Mukunda, CEO.

IGC has recently exited its legacy businesses and currently holds international investments in land and in a hotel project. An impressive and experienced team, led by Mr. Ram Mukunda, CEO, directs IGC.

Mr. Mukunda holds degrees in Electrical Engineering and Mathematics from the University of Maryland (UMD). He founded and served as Chairman and CEO of Startec Global Communications, an international telecommunications carrier focused on providing voice over Internet protocol (VOIP) services to emerging economies. Startec, the first pure play international long distance carrier, went public on NASDAQ. He has won a number of awards, including the 2013 University of Maryland International Alumnus of the year award. Mr. Mukunda serves as an Emeritus member on the Board of Visitors at the University of Maryland, School of Engineering, and has served as Council Member at Harvard's Kennedy School of Government, Belfer Center of Science and International Affairs. Mr. Mukunda and Dr. Krishna are the originators of all the IGC patent filings.

Dr. Ranga Krishna, Senior Advisor, is a Board Certified Neurologist with a sub specialty in Epilepsy surgery. He is the Director of Neurology at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College and the Director of Stroke Service at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College. He is the Medical Director and Chairman of Total Neuro Care, P.C. He is CEO of International Pharma Trials, Inc., which assists U.S. pharmaceutical companies perform Phase II clinical trials. Dr. Krishna is a member of several organizations, including the American Academy of Neurology and the Medical Society of the State of New York. He is also a member of the Medical Arbitration panel for the New York State Workers' Compensation Board and a Founding Member of the New York State Pain Society. Dr. Krishna was trained at New York's Mount Sinai Medical Center (1991-1994) and New York University (1994-1996). Dr. Krishna and Mr. Mukunda are the originators of all the IGC patent filings. Disclaimer

India Globalization Capital, Inc. Company Blog

India Globalization Capital, Inc. News:

IGC Acquires Exclusive Rights to THC-based treatment for Alzheimer’s Disease

India Globalization Capital, Inc. (NYSE: IGC) Taps Dr. Craig Cheifetz as Advisor for Clinical Trials of Cannabis-Based Combination Therapies

NetworkNewsWire Announces Editorial Discussing the Potential of Cannabis-Based Therapies for Pain Management

Stealth Technologies Inc. (STTH)

The QualityStocks Daily Newsletter would like to spotlight Stealth Technologies Inc. (STTH). Today, Stealth Technologies Inc. closed trading at $0.012, even for the day. The stock’s average daily volume over the past 60 days is 34,882, and its 52-week low/high is $0.01/$0.05.

Founded in 1999, Stealth Technologies Inc. (STTH) is focused on developing and marketing products that deliver cost effective, independently validated solutions for large addressable international and domestic markets. The company's primary target is identity protection and personal safety.

The Stealth Card represents the company's flagship solution for identity protection. Today there are more than 1.5 billion credit and debit cards in circulation with RFID chips, making it easier than ever for identity thieves to steal sensitive information without contact. The paper-thin Stealth Card offered by Stealth Technologies protects up to 12 RFID credit cards in a wallet without any batteries or charging requirements.

StealthIdentityTheft.com is an expansion of the company's commitment to provide first-rate identity protection solutions. The proprietary system underlying this identity protection and recovery service was designed in partnership with law enforcement officials. Utilizing the most effective methods of prevention involving a two-step process, StealthIdentityTheft.com is a superior answer to the non-stop identity theft taking place every day.

The international marketplace was infiltrated by Stealth Technologies when the company launched its 911 HELP NOW™ emergency medical alert device. Providing direct access with 911 service at a touch of a button, the device is packed with powerful features including a full year of battery life from standard AAA batteries, compact ergonomic design, 2-way voice and a durable, splash resistant design.

Stealth Mobile is the latest product offering introduced to leverage the Stealth Technologies' brand and sales channels established by the other products. Similar to the Stealth Card, Stealth Mobile prevents electronic pickpocketing. The product guards NFC transmissions emitted by cell phone devices, which can include personal information, messages and financial data.

Stealth Technologies recognizes the value of the rapid sales growth generated by these technologies and has multiple patents pending to safeguard its investments. With an expanding product suite and ongoing expansion into the identity theft protection marketplace, Stealth Technologies remains committed to its focus on increased growth and profitability. Disclaimer

Stealth Technologies Inc. Company Blog

Stealth Technologies Inc. News:

Stealth Technologies Announces 5 New Products

Stealth Technologies Highlights Opportunities from Attendance at Leading Real Estate, Home Staging Conference

NetworkNewsWire Releases Exclusive Audio Interview with Stealth Technologies, Inc. (STTH)


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Monster Alerts
(NAEI) +97.22%


MarketClub Analysis
(NVDQ) +95.00%


OnPoint Stock Alert
(GLMB) +50.00%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251